Latest News

Judy Lieberman, MD, PhD, the endowed chair in cellular and molecular medicine at Boston Children’s Hospital
Applying siRNA Therapy Beyond the Liver

March 28th 2024

Judy Lieberman, MD, PhD, the endowed chair in cellular and molecular medicine at Boston Children’s Hospital, discussed her research on siRNA technology.

Uttam Rao, MD, MBA
Uttam Rao, MD, MBA, on Comparing Conditioning Regimens for CAR-T

March 28th 2024

Around the Helix: Cell and Gene Therapy Company Updates – March 27, 2024
Around the Helix: Cell and Gene Therapy Company Updates – March 27, 2024

March 27th 2024

Naiyer Rizvi, MD, the chief medical officer of Synthekine
Synthekine Cleared to Tackle Lupus With CAR-T and IL-2 Combination Therapy in US Clinical Trial

March 27th 2024

SRP-9001 Improves DMD Disease Trajectory, But Falls Short on Primary End Point
SRP-9001 Improves DMD Disease Trajectory, But Falls Short on Primary End Point

March 27th 2024

Video Interviews

Conference Coverage

View All
Judy Lieberman, MD, PhD, the endowed chair in cellular and molecular medicine at Boston Children’s Hospital
Applying siRNA Therapy Beyond the Liver

March 28th 2024

Uttam Rao, MD, MBA
Uttam Rao, MD, MBA, on Comparing Conditioning Regimens for CAR-T

March 28th 2024

Understanding Disease Pathobiology Will be Key to Developing Cell Therapies for Autoimmune Disease
Understanding Disease Pathobiology Will be Key to Developing Cell Therapies for Autoimmune Disease

March 26th 2024

Vivien Sheehan, MD, PhD, an associate professor of pediatrics at Emory University
Vivien Sheehan, MD, PhD, on Choosing the Right Treatment Option for Patients With Sickle Cell Disease

March 26th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.